October 25, 2016 4:57 PM ET

Capital Markets

Company Overview of Omnes Capital S.A.S.

Company Overview

Omnes Capital is a venture capital and private equity firm specializing in direct and fund of fund investments. Within direct investments, the firm specializes in seed, startup, series A rounds, series B rounds, early venture, development stage, mid venture, late venture, emerging growth, growth capital, expansion, replacement capital, middle market, successions, small and mid-cap buyout, owner and leveraged buyout, mezzanine, PPP infrastructure, special situations, industry consolidation, mature, turnaround, and investing in small and medium enterprises. It is involved in all forms of business buy-ins/buyouts, on the occasion of inheritances, and in the form of spin-offs or delisting. Withi...

37 - 41 rue du Rocher

PARIS,  75008


Founded in 2000


33 1 80 48 79 00


33 1 42 93 48 55

Key Executives for Omnes Capital S.A.S.

Chief Executive Officer, Senior Partner, Chairman, Chairman of the Management Board, Chairman of the Executive Board, and Chairman of Executive Committee
Age: 57
Age: 49
Managing Director of Venture Capital and Tech and Member of Executive Committee
Age: 39
Age: 49
Managing Director of Renewable Energy, Managing Partner, Head of Renewable Energy, and Member of Executive Committee
Age: 42
Compensation as of Fiscal Year 2016.

Omnes Capital S.A.S. Key Developments

Omnes Capital Reportedly Seeks Acquisitions Through Newly Created Fund

Omnes Capital S.A.S. is seeking acquisitions through its newly created AMF-accredited FCPR (Fonds Communs de Placement à Risque) private equity fund for individuals wanting to invest in unlisted growth SMEs in France. The target size of the fund is €30 million, and it will make joint investments alongside the Omnes Mezzanis 3 FPCI fund managed by Omnes (target size of €150 million), a third-generation private debt fund dedicated to French SMEs and midcaps. The aim of the fund is to invest in French companies with a value of EUR50 million to €300 million presenting solid fundamentals, an experienced management team and strong potential for operational development and/or growth through acquisitions.

Omnes Capital S.A.S. Presents at BIO Trinity 2016, Apr-25-2016

Omnes Capital S.A.S. Presents at BIO Trinity 2016, Apr-25-2016 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Omnes Capital S.A.S. Presents at IN3 EuroMedTech 2015, Jun-10-2015 through Jun-11-2015

Omnes Capital S.A.S. Presents at IN3 EuroMedTech 2015, Jun-10-2015 through Jun-11-2015. Venue: Vienna Marriott Hotel, Parking 12A, 1010 Vienna, Austria. Presentation Date & Speakers: Jun-11-2015, Alexia Perouse, Head of Life Sciences and Partner.

Similar Private Companies By Industry

Company Name Region
2A Capital, SARL Europe
3S Finance Europe
66 NTH Europe
A+B Finance Europe
Abacuse Asset Management Europe

Recent Private Companies Transactions

Private Placement
October 20, 2016
Oxatis S.A.
September 30, 2016
September 29, 2016
Pommier SA

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Omnes Capital S.A.S., please visit www.omnescapital.com/en. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.